Showing 2,387 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Injectable & long-acting HIV treatment

ViiV Healthcare submits New Drug Application to US FDA for the first monthly, injectable, two-drug regimen of cabotegravir and rilpivirine

Editor's pick
ViiV press release
29 April 2019
New & experimental HIV treatments

ViiV Healthcare announces CHMP Positive Opinion for Dovato® (dolutegravir/lamivudine) as a once-daily, single-pill, two-drug regimen for the treatment of HIV infection

Editor's pick
ViiV press release
26 April 2019
Young people

The Listening Project: I’ll Speak About it All Day Long (sound file)

Editor's pick
BBC
25 April 2019
Transgender people

The largest study involving transgender people is providing long-sought insights about their health

Editor's pick
Nature
25 April 2019
HIV treatment for children & young people

U.S. Revises Pediatric HIV Treatment Guidelines

Editor's pick
Poz
23 April 2019
Side effects

A Promising Anti-HIV Drug Poses A Dilemma

Editor's pick
NPR
23 April 2019
Pharmaceutical industry

Gilead's first big TV push for triple combo Biktarvy showcases HIV diversity

Editor's pick
FiercePharma
18 April 2019
New & experimental HIV treatments

Novel Antibody May Suppress HIV for Up to Four Months

Editor's pick
NIAID
18 April 2019
Pregnancy and vertical transmission

Elvitegravir boosted with cobicistat: avoid use in pregnancy due to risk of treatment failure and maternal-to-child transmission of HIV-1

Editor's pick
Medicines and Healthcare products Regulatory Agency
17 April 2019
Injectable & long-acting HIV treatment

Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare

Editor's pick
The Body Pro
16 April 2019
Side effects

Weight gain with new antiretrovirals: It's complicated

Editor's pick
Spotlight
15 April 2019
Bad science & bogus treatments

He Jiankui's gene editing experiment ignored other HIV strains

Editor's pick
STAT
15 April 2019
Pharmaceutical industry

Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment?

Editor's pick
The Body
15 April 2019
Injectable & long-acting HIV treatment

Jose Arribas, MD, on the Challenges That Come With Long-Acting Injectables

Editor's pick
Contagion Live
15 April 2019
Side effects

Gilead Lawsuits: 41 HIV and PrEP Patients File California Personal Injury Case Over Gilead's TDF-Based Drugs

Editor's pick
Associated Press
12 April 2019
Treatment simplification strategies

FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment

Editor's pick
Food & Drug Administration
9 April 2019
Opportunistic infections

A Mysterious Infection, Spanning the Globe in a Climate of Secrecy

Editor's pick
New York Times
8 April 2019
Treatment guidelines

Avoiding Dolutegravir in Young Women With HIV: Time for a Rethink?

Editor's pick
MedPage Today
5 April 2019
Treatment simplification strategies

ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks

Editor's pick
ViiV press release
5 April 2019
Adherence

'Vast majority' of elevated viral load episodes in pregnant women caused by non-adherence

Editor's pick
Healio
2 April 2019
Treatment simplification strategies

Two-antiretroviral maintenance failure - raltegravir regimens seem most vulnerable

Editor's pick
NATAP
29 March 2019
Contraception

Efavirenz and rifampicin together reduce levels of injectable contraception

Editor's pick
HIV i-Base
29 March 2019
Contraception

Double-dose levonorgestrel implant does not overcome interaction with efavirenz

Editor's pick
HIV i-Base
29 March 2019
Side effects

HIV Drugs With Fewer Side Effects Need More FDA Support

Editor's pick
HivPlusMag.com
27 March 2019